Two Synthetic Peptides Corresponding to the Human Follicle-Stimulating Hormone β-Subunit Promoted Reproductive Functions in Mice.
Xingfa HanXinyu BaiHuan YaoWeihao ChenFengyan MengXiaohan CaoYong ZhuoLun HuaGuixian BuXiaogang DuQiuxia LiangXianyin ZengPublished in: International journal of molecular sciences (2022)
A follicle stimulating hormone (FSH) is widely used in the assisted reproduction and a synthetic peptide corresponding to a receptor binding region of the human (h) FSH-β-(34-37) (TRDL) modulated reproduction. Furthermore, a 13-amino acid sequence corresponding to hFSH-β-(37-49) (LVYKDPARPKIQK) was recently identified as the receptor binding site. We hypothesized that the synthetic peptides corresponding to hFSH-β-(37-49) and hFSH-β-(34-49), created by merging hFSH-β-(34-37) and hFSH-β-(37-49), modulate the reproductive functions, with the longer peptide being more biologically active. In male or female prepubertal mice, a single injection of 200 μg/g BW ip of hFSH-β-(37-49) or hFSH-β-(34-49) hastened ( p < 0.05) puberty, whereas the same treatments given daily for 4 d promoted ( p < 0.05) the gonadal steroidogenesis and gamete formation. In addition of either peptide to the in vitro cell cultures, promoted ( p < 0.05) the proliferation of primary murine granulosa cells and the estradiol production by upregulating the expression of Ccnd2 and Cyp19a1 , respectively. In adult female mice, 200 μg/g BW ip of either peptide during diestrus antagonized the FSH-stimulated estradiol increase and uterine weight gain during proestrus. Furthermore, hFSH-β-(34-49) was a more potent ( p < 0.05) reproductive modulator than hFSH-β-(37-49), both in vivo and in vitro. We concluded that hFSH-β-(37-49) and especially hFSH-β-(34-49), have the potential for reproductive modulation.
Keyphrases
- amino acid
- weight gain
- endothelial cells
- high fat diet induced
- body mass index
- induced apoptosis
- binding protein
- induced pluripotent stem cells
- birth weight
- signaling pathway
- single cell
- wild type
- physical activity
- cell therapy
- estrogen receptor
- insulin resistance
- cell proliferation
- oxidative stress
- long non coding rna
- polycystic ovary syndrome
- cell cycle arrest
- anti inflammatory
- mesenchymal stem cells
- dna binding
- climate change
- preterm birth
- pi k akt